14-day Premium Trial Subscription Try For FreeTry Free
Despite management guidance that points to significant revenue acceleration in the next two quarters, Accuray shares have languished. Market skepticism can be tied in part to the company's track recor
Accuray (ARAY) announces the latest data that supports the use of its CyberKnife System in the treatment of recurrent prostate cancer with stereotactic body radiation therapy.
Accuray's (ARAY) solid product demand raises optimism about the stock.
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock?

7 Screaming Stock Buys for Under $5

02:48pm, Wednesday, 21'st Feb 2024
While most financial advisors will probably steer you away from under $5 stocks, they have their benefits. Just like in football – the American kind – you can't just run up the gut.
The continued solid demand for Accuray's (ARAY) products raises optimism about the stock.
Despite robust Services revenues, Accuray (ARAY) reports dismal second-quarter fiscal 2024 results.
Accuray Incorporated (ARAY) Q2 2024 Earnings Call Transcript
The headline numbers for Accuray (ARAY) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estim
Besides Wall Street's top -and-bottom-line estimates for Accuray (ARAY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qu
Accuray's (ARAY) latest generation CyberKnife S7 System is expected to boost the cancer treatment capabilities of the Providence Swedish Radiosurgery Center.
MADISON, Wis. , Jan. 16, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2024, ended December 31, 2023, during a conferenc
The continued solid demand for Accuray's (ARAY) products raises optimism about the stock.
Accuray's (ARAY) VitalHold is likely to transform breast cancer treatment in Japan by integrating SGRT for precise radiotherapy. It may become a game-changer for patients and medical staff.
Accuray (ARAY) reports a solid fiscal first quarter top line on the back of robust Product revenues.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE